The association between ADH1B and ALDH2 genotypes and the prognosis and effect of treatment in esophageal cancer patients.

The association between ADH1B and ALDH2 genotypes and the prognosis and effect of treatment in esophageal cancer patients. - The association between ADH1B and ALDH2 genotypes and the prognosis and effect of treatment in esophageal cancer patients.

Status

Recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000035369

Enrollment

Registered

2019-01-01

Start date

2019-01-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

esophageal squamous cell carcinoma

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: pathologically proven esophageal cancer patients who give written consent to participate in this study

Exclusion criteria

Exclusion criteria: patients who do not treat esophageal caner, minors, patients who can not give consent

Design outcomes

Primary

Measure	Time frame
overall survival	—

Secondary

Measure	Time frame
progression-free survival, relapse-free survival, response rate, secondary primary malignancies	—

Countries

Japan

Contacts

Public ContactArakawa Yasuhiro

The Jikei University School of Medicine Medical Oncology and Hematology

yarakawa@jikei.ac.jp03-3433-1111

Outcome results